


Slim Weight Loss Clinic operates in Coral Gables, Florida, providing physician-supervised weight management programs centered on GLP-1 receptor agonist therapies. The clinic addresses obesity and metabolic health through structured protocols that combine prescription medications with individualized monitoring, serving patients throughout Miami-Dade County who require medical intervention for weight reduction.
The clinic's treatment portfolio includes three FDA-approved GLP-1 medications: liraglutide (administered as a daily subcutaneous injection), semaglutide (weekly injection protocol), and tirzepatide (a dual GIP/GLP-1 receptor agonist administered weekly). Each medication works by mimicking incretin hormones that regulate appetite, slow gastric emptying, and improve glycemic control. Patients undergo initial assessment to determine which peptide therapy aligns with their medical history, weight loss objectives, and tolerance profile. Dosing follows established titration schedules, starting at minimum effective doses and adjusting based on individual response and side effect management. The clinic monitors patients for common GLP-1 effects including nausea, gastrointestinal changes, and injection site reactions, adjusting protocols as needed to maintain treatment adherence.
Slim Weight Loss Clinic requires in-person consultations at their Coral Gables office, allowing providers to conduct physical examinations, review laboratory work, and establish baseline metabolic parameters before initiating peptide therapy. This face-to-face model enables direct assessment of contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Follow-up visits track weight trends, vital signs, and medication tolerance, with providers adjusting treatment plans based on objective clinical data rather than predetermined timelines.
Patients beginning GLP-1 therapy at the clinic receive instruction on proper injection technique, medication storage requirements, and recognition of adverse effects requiring medical attention. The clinic provides guidance on nutrition modifications that complement peptide therapy, emphasizing protein intake to preserve lean muscle mass during caloric restriction and hydration strategies to minimize gastrointestinal side effects. Appointments include discussion of realistic weight loss expectations, typically 10-15% body weight reduction over six months with semaglutide or tirzepatide when combined with lifestyle modification. The clinic does not guarantee specific outcomes but bases treatment decisions on published clinical trial data and individual patient response.
Slim Weight Loss Clinic's Coral Gables location serves patients seeking medical weight loss solutions who meet clinical criteria for GLP-1 therapy, generally defined as BMI of 30 or greater, or BMI of 27 or greater with weight-related comorbidities such as hypertension, dyslipidemia, or prediabetes. The in-person consultation model allows the clinic to maintain direct oversight of high-risk patients and those requiring frequent dose adjustments or additional metabolic testing. Patients interested in treatment contact the clinic to schedule an initial evaluation, during which providers determine eligibility for peptide therapy based on comprehensive health assessment and treatment goals.
Dr. Gary T. Marshall, MD, FACS
Surgeon
Practices in New York City.
Dr. Gary Kawesch, MD, FACS
Surgeon
Practices in Los Angeles.
Dr. Thierry Jacquemin, Board Certified
Physician
An international board-certified physician.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.

